LVW Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$958K Sell
13,876
-1,422
-9% -$98.1K 0.1% 113
2025
Q1
$1.06M Buy
15,298
+1,145
+8% +$79.5K 0.13% 98
2024
Q4
$1.22M Sell
14,153
-1,091
-7% -$93.8K 0.15% 94
2024
Q3
$1.82M Sell
15,244
-1,397
-8% -$166K 0.23% 65
2024
Q2
$2.38M Buy
16,641
+223
+1% +$31.8K 0.35% 43
2024
Q1
$2.11M Sell
16,418
-624
-4% -$80.1K 0.36% 46
2023
Q4
$1.76M Sell
17,042
-710
-4% -$73.5K 0.33% 52
2023
Q3
$1.61M Sell
17,752
-5,138
-22% -$467K 0.33% 61
2023
Q2
$1.85M Sell
22,890
-694
-3% -$56.2K 0.36% 61
2023
Q1
$1.88M Buy
23,584
+252
+1% +$20.1K 0.37% 62
2022
Q4
$1.58M Sell
23,332
-3,850
-14% -$261K 0.32% 69
2022
Q3
$1.35M Sell
27,182
-1,234
-4% -$61.5K 0.3% 67
2022
Q2
$1.58M Buy
28,416
+4,008
+16% +$223K 0.32% 63
2022
Q1
$1.36M Sell
24,408
-9,112
-27% -$506K 0.23% 71
2021
Q4
$1.88M Sell
33,520
-1,174
-3% -$65.7K 0.32% 66
2021
Q3
$1.67M Sell
34,694
-504
-1% -$24.2K 0.29% 66
2021
Q2
$1.47M Sell
35,198
-86
-0.2% -$3.6K 0.26% 68
2021
Q1
$1.19M Buy
35,284
+4,688
+15% +$158K 0.23% 70
2020
Q4
$1.07M Sell
30,596
-322
-1% -$11.3K 0.21% 69
2020
Q3
$1.07M Sell
30,918
-3,640
-11% -$126K 0.24% 67
2020
Q2
$1.13M Buy
34,558
+1,516
+5% +$49.6K 0.27% 60
2020
Q1
$995K Buy
33,042
+10,838
+49% +$326K 0.26% 65
2019
Q4
$643K Buy
22,204
+8,478
+62% +$246K 0.15% 89
2019
Q3
$355K Buy
+13,726
New +$355K 0.09% 114